In Brief: Microbiology Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Microbiology Devices Panel: FDA advisory panel unanimously votes (5-0) in favor of downclassification of automated short-term incubation cycle antimicrobial susceptibility devices from Class III to Class II at a Feb. 13 meeting in Rockville, Maryland. BioMerieux Vitek requested the downclassification in a petition submitted to the agency on July 24, 1997 ("The Gray Sheet" Aug. 18, I&W-6). Special controls recommended by the panel include an updated version of FDA's "Review Criteria for the Assessment of Antimicrobial Susceptibility Devices"...
You may also be interested in...
ATAI Raises $125m Series C To Expand The Boundaries In Mental Health
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.
10 Predictions On How Health Policy Could Change Under A Biden Presidency
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
Hologic Aptima Assay Cleared For HIV Detection
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: